UNRESECTABLE LIPOSARCOMA
Clinical trials for UNRESECTABLE LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LIPOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against rare sarcomas
Disease control OngoingThis study tests whether adding the targeted drug cabozantinib to immunotherapy (ipilimumab and nivolumab) works better than immunotherapy alone for people with advanced soft tissue sarcoma that has spread. About 66 adults with specific sarcoma types will receive either the combo…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute LAO • Aim: Disease control
Last updated May 26, 2026 11:03 UTC
-
New drug trial aims to tame rare sarcomas
Disease control OngoingThis early-stage study tests a drug called BTX-A51 in 24 people with advanced liposarcoma that has spread or come back. The main goal is to check if the drug is safe and tolerable at two different doses. Researchers will also watch for any tumor shrinkage or slowing of the diseas…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated May 20, 2026 11:56 UTC